/IGNE

IGNE Stock - Igene Biotechnology, Inc.

Q: What is the analyst price target for IGNE?

Analyst price target information is not currently available for IGNE.

Q: What is IGNE's market cap?

Market capitalization information is not currently available for IGNE.

Basic Materials|Agricultural Inputs|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for IGNE

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2003

FY2006

FY2007

FY2008

FY2009

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-23.34

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2009	FY2008	FY2007	FY2006	FY2003
Revenue	$3.96M	$7.64M	$2.29M	N/A	$463,486
Gross Profit	$1.02M	$1.25M	$605,098	N/A	$17,342
Gross Margin	25.7%	16.3%	26.5%	N/A	3.7%
Operating Income	$-1,069,869	$-2,188,290	$237,941	$-416,517	$-624,741
Net Income	$-140,747	$-3,990,937	$-1,899,073	$-1,155,773	$-2,199,141
Net Margin	-3.6%	-52.2%	-83.0%	N/A	-474.5%
EPS	$-0.00	$-0.02	$-0.02	$-0.01	$-0.02

Company Overview

Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.

Visit Website

Frequently Asked Questions about IGNE

What is IGNE's current stock price?

Igene Biotechnology, Inc. (IGNE) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for IGNE?

No analyst price targets are currently available for this stock.

What sector is Igene Biotechnology, Inc. in?

Igene Biotechnology, Inc. operates in the Basic Materials sector, specifically within the Agricultural Inputs industry. The company is traded on the OTC exchange.

What is IGNE's market cap?

Igene Biotechnology, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does IGNE pay dividends?

No, Igene Biotechnology, Inc. does not currently pay a dividend to shareholders.